The efficacy of a clinical trial is pivotal. The pharmacodynamic end point of choice is of great significance and we understand that this can range from the usual to the not yet developed. At 360biolabs, our highly skilled scientific team are capable of developing, innovating or simply tech transferring a pre-developed assay.
From cell based immunological assays measuring specific or customised panels via flow cytometry, ELISA, vaccine response via ELISPOT and anti-drug antibody (ADA) immunogenicity assessment, our experienced immunology team can deliver the assay you require.
Reinventing the wheel is not our philosophy. If current commercially available biomarker solutions including multiplex bead based array, ELISA and electrochemiluminescence (MSD®) immunoassay kits can provide the analysis you need, we can quickly verify a kit for clinical sample use.
360biolabs has an experienced molecular biology team with capabilities in quantitative and qualitative PCR , genotyping, sequencing and characterisation via SDS-PAGE and Western Blot.